HC Wainwright & Co. Maintains Buy on Verastem, Raises Price Target to $14

Benzinga · 05/09 12:45
HC Wainwright & Co. analyst Sean Lee maintains Verastem (NASDAQ:VSTM) with a Buy and raises the price target from $10 to $14.